These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25698578)

  • 1. miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.
    Mu W; Hu C; Zhang H; Qu Z; Cen J; Qiu Z; Li C; Ren H; Li Y; He X; Shi X; Hui L
    Cell Res; 2015 Apr; 25(4):477-95. PubMed ID: 25698578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumonisin B₁ modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b.
    Chuturgoon AA; Phulukdaree A; Moodley D
    Toxicol Lett; 2014 May; 227(1):50-5. PubMed ID: 24614526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.
    Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
    Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y
    Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.
    Chen D; Si W; Shen J; Du C; Lou W; Bao C; Zheng H; Pan J; Zhong G; Xu L; Fu P; Fan W
    Cell Death Dis; 2018 Feb; 9(2):188. PubMed ID: 29416005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA regulates the expression of human cytochrome P450 1B1.
    Tsuchiya Y; Nakajima M; Takagi S; Taniya T; Yokoi T
    Cancer Res; 2006 Sep; 66(18):9090-8. PubMed ID: 16982751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
    Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
    J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.
    Xiao Z; Li CH; Chan SL; Xu F; Feng L; Wang Y; Jiang JD; Sung JJ; Cheng CH; Chen Y
    Cancer Res; 2014 Nov; 74(21):6236-47. PubMed ID: 25217526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
    Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
    Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
    Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
    Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.